GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.8600
+0.0600 (7.50%)
At close: Apr 2, 2026, 4:00 PM EDT
0.8300
-0.0300 (-3.49%)
After-hours: Apr 2, 2026, 7:59 PM EDT
GlucoTrack Market Cap
GlucoTrack has a market cap or net worth of $869.7 thousand as of April 2, 2026. Its market cap has decreased by -78.55% in one year.
Market Cap
869.70K
Enterprise Value
-3.07M
1-Year Change
-78.55%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since April 25, 2013, GlucoTrack's market cap has decreased from $34.13M to $869.70K, a decrease of -97.45%. That is a compound annual growth rate of -24.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 869.70K | -75.32% |
| Dec 31, 2025 | 3.52M | -41.13% |
| Dec 31, 2024 | 5.99M | 9.59% |
| Dec 29, 2023 | 5.46M | -74.96% |
| Dec 30, 2022 | 21.82M | -66.12% |
| Dec 31, 2021 | 64.40M | -9.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nephros | 30.55M |
| Femasys | 26.52M |
| Harvard Bioscience | 22.97M |
| Milestone Scientific | 22.34M |
| Retractable Technologies | 20.58M |
| Regentis Biomaterials | 16.11M |
| Jin Medical International | 14.48M |
| Bionano Genomics | 13.31M |